版本:
中国

BRIEF-Bellerophon Therapeutics reports Q4 loss per share of $0.37

March 13 Bellerophon Therapeutics Inc

* Bellerophon reports fourth quarter 2016 financial results and provides business update

* Q4 loss per share $0.37

* Enrollment continues in Inovation-1, with topline results targeted in mid-2018 and interim read expected around end of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐